NL-OMON28109招募中不适用
The effect of body composition on the farmacokinetics of IFX in patients with inflammatory bowel disease
Zuyderland Medisch CentrumAfdeling MDL en Klinische farmacologie0 个研究点目标入组 33 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patiënt are eligible to participate in the study if all of the following criteria are met:
- •1. Patient, male or female, is aged above 18 years
排除标准
- •Patients are not eligible if one or more of the following criteria are met:
- •1. Patient is mentally or physically not able to participate to the study, including severe mental illness.
研究者
相似试验
暂停
不适用
The effect of body composition on the farmacokinetiek IFX in patients with inflammtoy bowel disease;Crohn's diseaseInflammatory Bowel DiseaseNL-OMON46317Zuyderland Medisch Centrum33
招募中
不适用
The effects of body composition on pharmacokinetics of propofolKCT0004196Chonbuk National University Hospital100
招募中
不适用
Investigating the impact of body composition on the activity of propofol in babies, infants and children undergoing anaesthesia.AnaesthesiaAnaesthesiology - AnaestheticsDiet and Nutrition - ObesityObesityACTRN12621000150842niversity of Auckland50
撤回
1 期
Doxorubicin Pharmacokinetic (PK) StudyCancerNCT00124956Boston Children's Hospital
招募中
Unknown
Body composition analysis by InBodyS10 and perioperative management of cardiovascular surgerycardiovascular diseaseJPRN-UMIN000049927St Marianna University School of Medicine200